|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Isomer-Specific Antidiabetic Properties of Conjugated Linoleic Acid
Improved Glucose Tolerance, Skeletal Muscle Insulin Action, and UCP-2 Gene Expression
1 Department of Clinical Physiology, Karolinska Institute, Stockholm Sweden
2 Department of Animal Sciences, Purdue University, West Lafayette, Indiana
3 Department of Biochemistry, Yeshiva University, Bronx; and the Departments of
4 Animal Science and
5 Food Science, Cornell University, Ithaca, New York
Conjugated linoleic acid (CLA) isomers have a number of beneficial health effects, as shown in biomedical studies with animal models. Previously, we reported that a mixture of CLA isomers improved glucose tolerance in ZDF rats and activated peroxisome proliferator–activated receptor (PPAR)-
response elements in vitro. Here, our aim was to elucidate the effect(s) of specific CLA isomers on whole-body glucose tolerance, insulin action in skeletal muscle, and expression of genes important in glucose and lipid metabolism. ZDF rats were fed either a control diet (CON), one of two CLA supplemented diets (1.5% CLA) containing differing isoforms of CLA (47% c9,t11; 47.9% c10,t12, 50:50; or 91% c9,t11, c9,t11 isomers), or were pair-fed CON diet to match the intake of 50:50. The 50:50 diet reduced adiposity and improved glucose tolerance compared with all other ZDF treatments. Insulin-stimulated glucose transport and glycogen synthase activity in skeletal muscle were improved with 50:50 compared with all other treatments. Neither phosphatidlyinositol 3-kinase activity nor Akt activity in muscle was affected by treatment. Uncoupling protein 2 in muscle and adipose tissue was upregulated by c9,t11 and 50:50 compared with ZDF controls. PPAR- mRNA was downregulated in liver of c9,t11 and pair-fed ZDF rats. Thus, the improved glucose tolerance in 50:50 rats is attributable to, at least in part, improved insulin action in muscle, and CLA effects cannot be explained simply by reduced food intake.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  R. N Close, D. A Schoeller, A. C Watras, and E. H Nora Conjugated linoleic acid supplementation alters the 6-mo change in fat oxidation during sleep Am. J. Clinical Nutrition, September 1, 2007; 86(3): 797 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Castaneda-Gutierrez, B. C. Benefield, M. J. de Veth, N. R. Santos, R. O. Gilbert, W. R. Butler, and D. E. Bauman Evaluation of the Mechanism of Action of Conjugated Linoleic Acid Isomers on Reproduction in Dairy Cows J Dairy Sci, September 1, 2007; 90(9): 4253 - 4264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Purushotham, A. A. Wendel, L.-F. Liu, and M. A. Belury Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice J. Lipid Res., February 1, 2007; 48(2): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Raff, T. Tholstrup, K. Sejrsen, E. M. Straarup, and N. Wiinberg Diets Rich in Conjugated Linoleic Acid and Vaccenic Acid Have No Effect on Blood Pressure and Isobaric Arterial Elasticity in Healthy Young Men J. Nutr., April 1, 2006; 136(4): 992 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Winzell, G. Pacini, and B. Ahren Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E347 - E354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. House, J. P. Cassady, E. J. Eisen, T. E. Eling, J. B. Collins, S. F. Grissom, and J. Odle Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice Physiol Genomics, May 11, 2005; 21(3): 351 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nagao, N. Inoue, Y.-M. Wang, B. Shirouchi, and T. Yanagita Dietary Conjugated Linoleic Acid Alleviates Nonalcoholic Fatty Liver Disease in Zucker (fa/fa) Rats J. Nutr., January 1, 2005; 135(1): 9 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Moloney, T.-P. Yeow, A. Mullen, J. J Nolan, and H. M Roche Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus Am. J. Clinical Nutrition, October 1, 2004; 80(4): 887 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Riserus, A. Smedman, S. Basu, and B. Vessby Metabolic effects of conjugated linoleic acid in humans: the Swedish experience Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1146S - 1148S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang and P. J. Jones Dietary conjugated linoleic acid and body composition Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1153S - 1158S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V Aminot-Gilchrist and H. D. Anderson Insulin resistance--associated cardiovascular disease: potential benefits of conjugated linoleic acid Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1159S - 1163S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Lin, J. J. Loor, and J. H. Herbein Trans10,cis12-18:2 Is a More Potent Inhibitor of De Novo Fatty Acid Synthesis and Desaturation than cis9,trans11-18:2 in the Mammary Gland of Lactating Mice J. Nutr., June 1, 2004; 134(6): 1362 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lajoie, A. Calderone, F. Trudeau, N. Lavoie, G. Massicotte, S. Gagnon, and L. Beliveau Exercise training attenuated the PKB and GSK-3 dephosphorylation in the myocardium of ZDF rats J Appl Physiol, May 1, 2004; 96(5): 1606 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Terpstra Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature Am. J. Clinical Nutrition, March 1, 2004; 79(3): 352 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Masso-Welch, D. Zangani, C. Ip, M. M. Vaughan, S. F. Shoemaker, S. O. McGee, and M. M. Ip Isomers of Conjugated Linoleic Acid Differ in Their Effects on Angiogenesis and Survival of Mouse Mammary Adipose Vasculature J. Nutr., February 1, 2004; 134(2): 299 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Hauswirth, M. R.L. Scheeder, and J. H. Beer High {omega}-3 Fatty Acid Content in Alpine Cheese: The Basis for an Alpine Paradox Circulation, January 6, 2004; 109(1): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Larsen, S. Toubro, and A. Astrup Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies J. Lipid Res., December 1, 2003; 44(12): 2234 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Brown and M. K. McIntosh Conjugated Linoleic Acid in Humans: Regulation of Adiposity and Insulin Sensitivity J. Nutr., October 1, 2003; 133(10): 3041 - 3046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. M. Terpstra, M. Javadi, A. C. Beynen, S. Kocsis, A. E. Lankhorst, A. G. Lemmens, and I. C. M. Mohede Dietary Conjugated Linoleic Acids as Free Fatty Acids and Triacylglycerols Similarly Affect Body Composition and Energy Balance in Mice J. Nutr., October 1, 2003; 133(10): 3181 - 3186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Brown, M. S. Boysen, S. S. Jensen, R. F. Morrison, J. Storkson, R. Lea-Currie, M. Pariza, S. Mandrup, and M. K. McIntosh Isomer-specific regulation of metabolism and PPAR{gamma} signaling by CLA in human preadipocytes J. Lipid Res., July 1, 2003; 44(7): 1287 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Henriksen, M. K. Teachey, Z. C. Taylor, S. Jacob, A. Ptock, K. Kramer, and O. Hasselwander Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E98 - E105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Mir, Z. Mir, P. S. Kuber, C. T. Gaskins, E. L. Martin, M. V. Dodson, J. A. Elias Calles, K. A. Johnson, J. R. Busboom, A. J. Wood, et al. Growth, carcass characteristics, muscle conjugated linoleic acid (CLA) content, and response to intravenous glucose challenge in high percentage Wagyu, Wagyu x Limousin, and Limousin steers fed sunflower oil-containing diets J Anim Sci, November 1, 2002; 80(11): 2996 - 3004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Riserus, P. Arner, K. Brismar, and B. Vessby Treatment With Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men With the Metabolic Syndrome Diabetes Care, September 1, 2002; 25(9): 1516 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Roche, E. Noone, C. Sewter, S. Mc Bennett, D. Savage, M. J. Gibney, S. O'Rahilly, and A. J. Vidal-Puig Isomer-Dependent Metabolic Effects of Conjugated Linoleic Acid: Insights From Molecular Markers Sterol Regulatory Element-Binding Protein-1c and LXR{alpha} Diabetes, July 1, 2002; 51(7): 2037 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rodriguez, J. Ribot, and A. Palou trans-10, cis-12, but not cis-9, trans-11 CLA isomer, inhibits brown adipocyte thermogenic capacity Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1789 - R1797. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |